Purenum

Exit

Purenum is a spin-off of the Fraunhofer-IFAM and develops biocompatible adhesives for medical use. As part of a BMBF project (GO-Bio 6 "mediNiK"), an adhesive was developed that can be used to glue together and remove previously ungrippable kidney stone fragments after lithotripsy. In addition to work on the commercialisation of the kidney stone adhesive, Purenum is also developing adhesives for other medical indications.

Press releases

Press
Purenum
14. June 2023

Successful Exit for HTGF: FARCO-PHARMA acquires MedTech Startup Purenum GmbH

Cologne, 14 June 2023: FARCO-PHARMA, a company of the Klosterfrau Healthcare Group, is acquiring Purenum GmbH, which was founded in 2017. The MedTech start-up will operate as a wholly owned subsidiary of FARCO-PHARMA and will continue to drive forward its work in the area of research & development. The seed investor High-Tech Gründerfonds (HTGF), the investment company of BAB – Die Förderbank and FRIBA Investment have closely supported Purenum GmbH since 2018 and are selling thei
 

Info & Contact

Address

Fahrenheitstr. 1
D-28359 Bremen

In portfolio

16. Jul 2018 – 14. Jun 2023

Sector

HTGF Manager

 
Dr. Anke Caßing, Principal / Authorized Signatory
Exit